Seriously, I’ve been accused of putting out dumb posts but come on. Generex does have a big deal signing in the next two weeks that implies the peptide testing looks good.

On top of that, NGIO listing looks good for possibly October which will improve the financials of Generex and all shareholders.

I don’t like the PPS right now. It sucks, but the potential is still very very high for success.